Sinew Pharma Inc. (TPEX:6634)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
35.30
+0.35 (1.00%)
Jan 21, 2026, 1:30 PM CST
-28.11%
Market Cap2.59B
Revenue (ttm)n/a
Net Income (ttm)-141.91M
Shares Out71.32M
EPS (ttm)-1.99
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume38,358
Average Volume47,713
Open35.00
Previous Close34.95
Day's Range34.50 - 35.30
52-Week Range33.30 - 59.40
Beta-0.21
RSI41.59
Earnings DateNov 14, 2025

About Sinew Pharma

Sinew Pharma Inc., a biopharmaceutical company, focuses on the research, development, and sale of drugs for the treatment of hepatotoxicity-free acetaminophen and fatty liver diseases. The company’s products include SNP-610 drug, which is in Phase IIa clinical trial and SNP-630 drug, which is in Phase II clinical trial for treating patients with non-alcoholic steatohepatitis in Taiwan. It is also developing SNP-810 is in phase II clinical trial for use in pain relief and fever reduction; SNP-820 is in Phase II clinical trial for antidote for ac... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2014
Employees 52
Stock Exchange Taipei Exchange
Ticker Symbol 6634
Full Company Profile

Financial Performance

Financial Statements